Successful Treatment of Sudden Hepatitis Induced by Long-Term Nivolumab Administration

Immune checkpoint inhibitors have drastically changed in the treatment of many kinds of malignancies, especially malignant melanoma. The focus of the recent experiments has not only been on their efficacy but also immune-related adverse events (irAEs). We report a case of fulminant hepatitis due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Imafuku, Keisuke, Yoshino, Koji, Yamaguchi, Kei, Tsuboi, Satoshi, Ohara, Kuniaki, Hata, Hiroo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436031/
https://www.ncbi.nlm.nih.gov/pubmed/28559821
http://dx.doi.org/10.1159/000471480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436031/
https://www.ncbi.nlm.nih.gov/pubmed/28559821
http://dx.doi.org/10.1159/000471480

Ejemplares similares